Su J - Search Results

1

A randomized, controlled trial of oral propranolol in infantile hemangioma.

Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, Phillips RJ, Caceres H, Lopez Gutierrez JC, Ballona R, Friedlander SF, Powell J, Perek D, Metz B, Barbarot S, Maruani A, Szalai ZZ, Krol A, Boccara O, Foelster-Holst R, Febrer Bosch MI, Su J, Buckova H, Torrelo A, Cambazard F, Grantzow R, Wargon O, Wyrzykowski D, Roessler J, Bernabeu-Wittel J, Valencia AM, Przewratil P, Glick S, Pope E, Birchall N, Benjamin L, Mancini AJ, Vabres P, Souteyrand P, Frieden IJ, Berul CI, Mehta CR, Prey S, Boralevi F, Morgan CC, Heritier S, Delarue A, Voisard JJ. Léauté-Labrèze C, et al. Among authors: su j. N Engl J Med. 2015 Feb 19;372(8):735-46. doi: 10.1056/NEJMoa1404710. N Engl J Med. 2015. PMID: 25693013 Free article. Clinical Trial.

2

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.

Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, Biswas P, Malhotra B, Zhang F, Valdez H; JADE COMPARE Investigators. Bieber T, et al. N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380. N Engl J Med. 2021. PMID: 33761207 Clinical Trial.

3

Effect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia.

Akdim F, Visser ME, Tribble DL, Baker BF, Stroes ES, Yu R, Flaim JD, Su J, Stein EA, Kastelein JJ. Akdim F, et al. Among authors: su j. Am J Cardiol. 2010 May 15;105(10):1413-9. doi: 10.1016/j.amjcard.2010.01.003. Epub 2010 Mar 30. Am J Cardiol. 2010. PMID: 20451687 Clinical Trial.

4

Efficacy and safety of mipomersen, an antisense inhibitor of apolipoprotein B, in hypercholesterolemic subjects receiving stable statin therapy.

Akdim F, Stroes ES, Sijbrands EJ, Tribble DL, Trip MD, Jukema JW, Flaim JD, Su J, Yu R, Baker BF, Wedel MK, Kastelein JJ. Akdim F, et al. Among authors: su j. J Am Coll Cardiol. 2010 Apr 13;55(15):1611-8. doi: 10.1016/j.jacc.2009.11.069. J Am Coll Cardiol. 2010. PMID: 20378080 Free article. Clinical Trial.

5

Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemia.

Akdim F, Tribble DL, Flaim JD, Yu R, Su J, Geary RS, Baker BF, Fuhr R, Wedel MK, Kastelein JJ. Akdim F, et al. Among authors: su j. Eur Heart J. 2011 Nov;32(21):2650-9. doi: 10.1093/eurheartj/ehr148. Epub 2011 May 18. Eur Heart J. 2011. PMID: 21593041 Clinical Trial.

6

Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B.

Kastelein JJ, Wedel MK, Baker BF, Su J, Bradley JD, Yu RZ, Chuang E, Graham MJ, Crooke RM. Kastelein JJ, et al. Among authors: su j. Circulation. 2006 Oct 17;114(16):1729-35. doi: 10.1161/CIRCULATIONAHA.105.606442. Epub 2006 Oct 9. Circulation. 2006. PMID: 17030687 Clinical Trial.

7

Prediction of clinical responses in a simulated phase III trial of Crohn's patients administered the antisense phosphorothioate oligonucleotide ISIS 2302: comparison of proposed dosing regimens.

Yu RZ, Su JQ, Grundy JS, Geary RS, Sewell KL, Dorr A, Levin AA. Yu RZ, et al. Antisense Nucleic Acid Drug Dev. 2003 Feb;13(1):57-66. doi: 10.1089/108729003764097340. Antisense Nucleic Acid Drug Dev. 2003. PMID: 12691536 Clinical Trial.

8

Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans.

Graham MJ, Lee RG, Bell TA 3rd, Fu W, Mullick AE, Alexander VJ, Singleton W, Viney N, Geary R, Su J, Baker BF, Burkey J, Crooke ST, Crooke RM. Graham MJ, et al. Among authors: su j. Circ Res. 2013 May 24;112(11):1479-90. doi: 10.1161/CIRCRESAHA.111.300367. Epub 2013 Mar 29. Circ Res. 2013. PMID: 23542898 Clinical Trial.

9

Activation of AMPK inhibits cervical cancer growth by hyperacetylation of H3K9 through PCAF.

Pan B, Liu C, Su J, Xia C. Pan B, et al. Among authors: su j. Cell Commun Signal. 2024 Jun 3;22(1):306. doi: 10.1186/s12964-024-01687-7. Cell Commun Signal. 2024. PMID: 38831454

10

Unveiling Highly Sensitive Active Site in Atomically Dispersed Gold Catalysts for Enhanced Ethanol Dehydrogenation.

Yang J, Zheng J, Dun C, Falling LJ, Zheng Q, Chen JL, Zhang M, Jaegers NR, Asokan C, Guo J, Salmeron M, Prendergast D, Urban JJ, Somorjai GA, Guo Y, Su J. Yang J, et al. Among authors: su j. Angew Chem Int Ed Engl. 2024 Jun 3:e202408894. doi: 10.1002/anie.202408894. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 38830120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,508 results

Search Page